Novus Remedies Private Limited, a active private limited company, was established on 29 July 2008 in Mumbai, Maharashtra, India. Engaging in solar energy solutions within the trade sector, it holds CIN: U40100MH2008PTC185174. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 3 professional, Its leadership includes Vijay Balasaheb Shinde (Additional Director), Omprakash Sitaram Saraf (Director), Ashish Omprakash Saraf (Director). Past directors included Manju Om Saraf, Rupesh Ramdaras Vishwakarma, Omprakash Sitaram Saraf. It holds ₹1.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No. 103 A Wing Dlh Junction Of Eversun Chsl J P Road Sahakar Nagar Andheri West, Mumbai, Maharashtra, 400053.
U40100MH2008PTC185174
185174
29 July 2008
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Novus Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijay Balasaheb Shinde | Additional Director | 02 Jan 2024 | Current |
| Omprakash Sitaram Saraf | Director | 10 Dec 2022 | Current |
| Ashish Omprakash Saraf | Director | 01 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Mar 2022 | Past |
| Pramod Abcsdd | Director | 10 Dec 2022 | Past |
| Pramod Abcsdd | Director | 12 Sep 2019 | Past |
| Pramod Abcsdd | Director | 12 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Novus Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.71% increase. The company also saw a substantial improvement in profitability, with a 34.81% increase in profit. The company's net worth Soared by an impressive increase of 14.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Novus Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹10,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Dec 2024 | Others | ₹6.00 M | Open |
| 23 Sep 2023 | Others | ₹4.00 M | Open |
Explore comprehensive loan charge details -
Novus Remedies has a workforce of 3 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Novus Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novus Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 6.00 M with Charge ID 101050448 was registered on 19 Dec 2024. was recorded as a recent event.
Progress on Novus Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Novus Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity Vijay Balasaheb Shinde was appointed as a Additional Director was appointed as a Additional Director on 02 Jan 2024 & has been associated with this company since 1 year 10 months . was completed.
Progress on A charge with Others amounted to Rs. 4.00 M with Charge ID 100837983 was registered on 23 Sep 2023. was documented.
The activity Omprakash Sitaram Saraf was appointed as a Director was appointed as a Director on 10 Dec 2022 & has been associated with this company since 2 years 11 months . was completed.
The CIN of Novus Remedies Private Limited is U40100MH2008PTC185174.
Novus Remedies Private Limited is headquartered at Office No. 103 A Wing Dlh Junction Of Eversun Chsl J P Road Sahakar Nagar Andheri West, Mumbai, Maharashtra, 400053.
Novus Remedies Private Limited was incorporated on 29 July 2008.
The current directors of Novus Remedies Private Limited are
The primary industry of Novus Remedies Private Limited is Trade.
Novus Remedies Private Limited is unlisted.
The authorized capital of Novus Remedies Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Novus Remedies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX